Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3. Januar 2020 INDIZES USA

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, granted six newly-hired …
(Orginal – Story lesen…)

Tags: dow jones nasdaq s&p 500

You may also like...